GroundRules
O.C.G.A. § 31-52-4: Eligibility criteria.
Where this section sits in the code
- TITLE 31 Health
- CHAPTER 52 Terminally Ill Patient’s Right To Try Investigational Drugs, Biological Products, and Devices
In order for a person to be considered an eligible patient to access an investigational drug, biological product, or device pursuant to this chapter, a physician must document in writing that the person:
(1) Has a terminal illness;
(2) Has, in consultation with the physician, considered all other treatment options currently approved by the federal Food and Drug Administration;
(3) Has been given a recommendation by the physician for an investigational drug, biological product, or device; and
(4) Has given written informed consent for the use of the investigational drug, biological product, or device.
Collected 2026-09-17T19:34:57Z. Source file · JSON